Satiogen Pharmaceuticals, Inc.
Records under this name other than the patents Satiogen Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
Showing 1 to 2 of 2 · Back to Satiogen Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,555,950 | Bile acid recycling inhibitors for treatment of obesity and diabetes Lapsed on the fee record Ended Feb 11, 2024 · From the USPTO record | Lapsed on the fee record | Ended Feb 11, 2024 | From the USPTO record |
| US 8,366,650 | Biliary/pancreatic shunt device and method for treatment of metabolic and other diseases Lapsed on the fee record Ended Feb 5, 2021 · From the USPTO record | Lapsed on the fee record | Ended Feb 5, 2021 | From the USPTO record |